After Plunging -7.62% in 4 Weeks, Here's Why the Trend Might Reverse for McKesson (MCK)Zacks Investment Research • 03/01/23
McKesson (MCK) Announces Availability of FDA-Cleared Drug for MCLZacks Investment Research • 02/15/23
Warren Buffett Didn't Buy a Single New Stock to End 2022. But He Cut From 8.The Motley Fool • 02/15/23
Here's Why McKesson (MCK) is Poised for a Turnaround After Losing -6.24% in 4 WeeksZacks Investment Research • 02/07/23
McKesson Receives Approval of Its Near-term Climate Change Targets by the Globally Recognized Science Based Targets initiativeBusiness Wire • 01/23/23
These were Warren Buffett's 10 best performing stocks held by Berkshire Hathaway in 2022Business Insider • 01/04/23